Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIPER-BP: Intensified BP Management with Valsartan
NCT00902304Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of valsartan in hypertension (HTN), sponsored by Novartis. Primary endpoint: Percentage of Patients Who Have Achieved Their Pre-specified Blood Pressure Target at 26 weeks. Started Jul 2009; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00902304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902304.